SSR-240612

SSR-240612

Cat. No.: DIA-0230216

Size: 1 mg Size: 50 mg Size: Customer Size
Product Information
CAS No. 464930-42-5
Chemical Name (3R)-3-(1,3-benzodioxol-5-yl)-N-[(6-methoxy-2-naphthalenyl)sulfonyl]-β-alanyl-4-[[(2R,6S)-2,6-dimethyl-1-piperidinyl]methyl]-N-methyl-N-(1-methylethyl)-D-phenylalaninamide, monohydrochloride
Formula C42H52N4O7S
Molecular Weight 793.40
PubChem CID 44235958
SMILES CC1CCCC(N1CC2=CC=C(C=C2)CC(C(=O)N(C)C(C)C)NC(=O)CC(C3=CC4=C(C=C3)OCO4)NS(=O)(=O)C5=CC6=C(C=C5)C=C(C=C6)OC)C.Cl
Target Zinc Finger
Product Description Bradykinin B1 receptor antagonist
Format & Storage
Purity > 98%
Shipping Shipped on dry ice.
Storage Store at -20 °C.
Solubility Overview Soluble in DMSO to 25 mM
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top